Hormone therapy is widely used to treat menopausal symptoms such as hot flashes and night sweats. But scientists have long ...
Health and Me on MSN
Weight loss drug semaglutide cannot slow down Alzheimer’s: Lancet study
Evoke and Evoke+ -- the randomized, double-blind, placebo-controlled phase 3 trials conducted across 566 sites in 40 ...
The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...
Eye imaging may help distinguish ALS from Alzheimer’s disease by revealing differences in retinal protein deposits using polarized light.
EatingWell on MSN
You just found out that you’re at risk for dementia—here’s what experts say to do first
Small actions today can help reduce your dementia risk.
GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...
Researchers say a simple blood test could help flag which older women face a higher risk of dementia long before any symptoms ...
"Advances in biomarker technology, digital cognitive assessments, and amyloid-targeting therapies have redefined the opportunities for accurate and early diagnosis and care of Alzheimer's disease," ...
Alzheimer’s disease is the most common cause of dementia, a condition that slowly damages memory, thinking ability, and daily functioning. Millions of people around the world live with Alzheimer’s, ...
If ever you needed a nudge to give your brain a workout, new research underscoring the benefits of “brain training” should offer fresh motivation.
The growing research on brain health is a good reminder that while our phones might offer a quick dopamine hit, real ...
Paul Bellamy said he had seen a huge difference in people before and after the sessions Music sessions for those with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results